Literature DB >> 20673977

Successful use of omalizumab for prevention of fire ant anaphylaxis.

Hana M Tartibi, Amee R Majmundar, David A Khan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20673977     DOI： 10.1016/j.jaci.2010.06.014

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  5 in total

Review 1.  Off-Label Uses of Omalizumab.

Authors:  David El-Qutob
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

Review 2.  Use of omalizumab in the treatment of food allergy and anaphylaxis.

Authors:  Jay A Lieberman; Mirna Chehade
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

3.  The bee sting that was not: an unusual case of hymenoptera anaphylaxis averted in a patient treated with omalizumab for asthma.

Authors:  Evelyn M Slaughter; Nathan Boyer; Steven Bennett
Journal:  Case Rep Med       Date:  2014-08-12

4.  Exercise-induced anaphylaxis: a case report and review of the diagnosis and treatment of a rare but potentially life-threatening syndrome.

Authors:  Nathan T Jaqua; Matthew R Peterson; Karla L Davis
Journal:  Case Rep Med       Date:  2013-03-27

5.  Long-term omalizumab use in the treatment of exercise-induced anaphylaxis.

Authors:  Mark R Peterson; Christopher A Coop
Journal:  Allergy Rhinol (Providence)       Date:  2017-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.